AIM IMMUNOTECH INC. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
AIM IMMUNOTECH INC. (AIM) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $3.62 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Debt › Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2026-08-07
- 2026-06-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $3.62M.
- 2026-03-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $4.21M.
- 2025-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $4.48M.
- 2025-06-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $2.29M.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net |
|---|---|
| 2026-06-30 | $3.62M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $4.21M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $4.48M 10-Q · filed 2026-08-07 |
| 2025-06-30 | $2.29M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.95M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $2.31M 10-K · filed 2026-03-27 |
| 2024-09-30 | $2.73M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $2.64M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.57M 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |